Denmark Press Releases

Published on March 4, 2024 - 08:15 GMT

Woman Offside - A Year with Lise Klaveness

New book released on International Women’s Day chronicles a year in the life of Lise Klaveness, President of the Norway Football Federation SYDNEY, AUSTRALIA, March 4, 2024 /⁨EINPresswire.com⁩/ -- A compelling new book to be released on International …

Distribution channels: Book Publishing Industry, Sports, Fitness & Recreation ...

Published on March 3, 2024 - 08:00 GMT

GN launches The New Norm – a stigma-busting image bank that challenges misperceptions about hearing loss and hearing aids

A Media Snippet accompanying this announcement is available by clicking on this link. Globally, 4 out of 5 people who need hearing aids don't wear them, leaving an estimated 344 million people missing out on the sounds of life, communicating and …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...

Published on March 2, 2024 - 18:14 GMT

Dansk Udlandsrekruttering har åbnet op for unge, som vil have sabbatår i udlandet

Der er nu åbent for unge danskere, som vil holde sabbatår i udlandet. Første ansøgere har allerede fundet job og der er flere muligheder end nogensinde. AALBORG, DANMARK, March 2, 2024 /⁨EINPresswire.com⁩/ -- Dansk Udlandsrekruttering, som hjælper unge …

Distribution channels: Travel & Tourism Industry ...

Published on March 1, 2024 - 19:00 GMT

NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease ...

NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences ClC-1 is a chloride ion channel specifically expressed in skeletal muscle cells that normally dampens muscle fiber …

Distribution channels:

Published on March 1, 2024 - 16:00 GMT

Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference

Press release – No. 3 / 2023 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 1, 2024 - 14:11 GMT

Evaxion veranstaltet am 19. März 2024 F&E-Tag zur Vorstellung seiner neuesten technologischen Innovationen

KOPENHAGEN, Dänemark, March 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) („Evaxion“ oder das „Unternehmen“), ein im klinischen Stadium tätiges TechBio-Unternehmen, das sich auf die Entwicklung von AI-Immunology™-gestützten Impfstoffen …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 1, 2024 - 14:11 GMT

Evaxion organisera une journée R&D le 19 mars 2024 lors de laquelle elle mettra en avant ses dernières innovations technologiques

COPENHAGUE, Danemark, 01 mars 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX) (« Evaxion » ou la « Société »), une société de biotechnologie spécialisée dans la recherche clinique et le développement de vaccins élaborés grâce à AI-Immunology™, …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 1, 2024 - 09:55 GMT

MULIG NY OBLIGATIONSUDSTEDELSE

INVESTOR NEWS nr. 13 - 1. marts 2024 DFDS, der har en issuer rating på BBB- Stable fra Scope Ratings, har til hensigt at udstede senior usikrede obligationer i NOK med en forventet løbetid på 3-5 år i den nærmeste fremtid. Danske Bank, Nykredit og SEB …

Distribution channels: Media, Advertising & PR, Shipping, Storage & Logistics ...

Published on March 1, 2024 - 09:55 GMT

POTENTIAL NEW BOND ISSUE

INVESTOR NEWS no. 13 - 1 March 2024 DFDS, rated BBB-/Stable by Scope Ratings, intends to issue NOK denominated senior unsecured bonds with expected tenors of 3-5 years in the near future. Danske Bank, Nykredit, and SEB have been mandated to arrange a …

Distribution channels: Media, Advertising & PR, Shipping, Storage & Logistics ...

Published on February 29, 2024 - 19:02 GMT

Diasome Pharmaceuticals Launches Groundbreaking OPTI-2 Phase 2b Trial in Type 1 Diabetes

CLEVELAND, OH, UNITED STATES, February 29, 2024 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel liver targeting drug platform, announced today the initiation of the OPTI-2 Phase 2b …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 29, 2024 - 12:30 GMT

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

COPENHAGEN, Denmark, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announces that it will host a …

Distribution channels:

Published on February 28, 2024 - 17:31 GMT

Driving Innovation: DI Dansk Industri, Green Power Denmark & State of Green Named Host Partners for World Hydrogen Week

We are delighted to announce that we are partnering with three prominent leaders driving the local and global hydrogen transition from our new host nation. LONDON, LONDON, UNITED KINGDOM, February 28, 2024 /⁨EINPresswire.com⁩/ -- Last year's Danish …

Distribution channels: Aviation & Aerospace Industry, Banking, Finance & Investment Industry ...

Published on February 28, 2024 - 11:00 GMT

Allarity Therapeutics to Present at Biomarkers 2024

Boston (February 28, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, is pleased to announce that it has been invited to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 27, 2024 - 18:58 GMT

New Book Challenges AI Implementations

"Applying Artificial Intelligence – The Practitioner’s Handbook" by Dan Rose Johansen COPENHAGEN, DENMARK, February 27, 2024 /⁨EINPresswire.com⁩/ -- In an era where Artificial Intelligence (AI) technology promises unparalleled business …

Distribution channels: Book Publishing Industry, Business & Economy ...

Published on February 27, 2024 - 09:46 GMT

HRbrain.ai Unveils Critical DE&I Insights in European Workplaces from Global Study

Employees who perceive their workplace policies as not inclusive are twice as likely to be actively looking for new employment opportunities elsewhere TEXAS, USA, February 27, 2024 /⁨EINPresswire.com⁩/ -- HRbrain.ai, a leader in AI-powered HR solutions, …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...

Published on February 27, 2024 - 06:00 GMT

Zealand Pharma Announces Financial Results for the Full Year 2023

Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a solid financial position Positive results achieved for …

Distribution channels:

Published on February 26, 2024 - 11:53 GMT

Desk Research Group Celebrates Success in Assisting Ambitious Global Expansion

Forward-thinking business consulting firm crosses a milestone in strategic growth support. MALAGA, SPAIN, February 26, 2024 /⁨EINPresswire.com⁩/ -- The right strategy and understanding the market in a comprehensive way can be the difference between …

Distribution channels: Business & Economy, Companies ...

Published on February 26, 2024 - 12:00 GMT

MC2 Therapeutics to Present at Upcoming Conferences

MC2 Therapeutics to Present at Upcoming Conferences Copenhagen, February 26th, 2024 – MC2 Therapeutics, a commercial stage biotech company focused on developing novel treatment paradigms within immunology and inflammation, announces today that its …

Distribution channels:

Published on February 26, 2024 - 07:06 GMT

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking ...

Company announcement - No. 8 / 2024 Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis Survodutide …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 23, 2024 - 06:35 GMT

Bavarian Nordics vaccinekandidat mod chikungunya er blevet tildelt fremskyndet vurdering af Det Europæiske Lægemiddelagentur

Fremskyndet vurdering muliggør en kortere behandlingstid for godkendelsesansøgningen hos EMA. Bavarian Nordic forventer at indsende ansøgning om markedsføringstilladelse for CHIKV VLP til EMA i første halvår 2024. KØBENHAVN, Danmark, 23. februar 2024 – …

Distribution channels: Technology ...

Denmark Press Releases Distributed by EIN Presswire